Strattera and Premature ejaculation - a phase IV clinical study of FDA data

Summary:

Premature ejaculation is reported as a side effect among people who take Strattera (atomoxetine hydrochloride), especially for people who are 30-39 old, have been taking the drug for < 1 month also take Albuterol, and have Ill-defined disorder.

The phase IV clinical study analyzes which people have Premature ejaculation when taking Strattera. It is created by eHealthMe based on reports of 27,428 people who have side effects when taking Strattera from the FDA, and is updated regularly.

What is Strattera?

Strattera has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,324 Strattera users. Check the latest studies of Strattera.

What is Premature ejaculation?

Premature ejaculation is found to be associated with 32 drugs and 173 conditions by eHealthMe. Check the latest studies of Premature ejaculation.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

27,428 people reported to have side effects when taking Strattera.
Among them, 26 people (0.09%) have Premature ejaculation.

Could Strattera cause Premature ejaculation?

Among these 26 people:

How long have people been on Strattera when they have Premature ejaculation? *

What is the age of people who have Premature ejaculation when taking Strattera? *

What are other drugs people take besides Strattera? *

What are other side effects people have besides Premature ejaculation? *

Erection Problems: 9 people, 34.62%
Insomnia (sleeplessness): 5 people, 19.23%
Urination - Painful: 4 people, 15.38%
Disturbance In Attention: 2 people, 7.69%
Fatigue (feeling of tiredness): 2 people, 7.69%
Ejaculation Disorder: 2 people, 7.69%
Hypotension (abnormally low blood pressure): 2 people, 7.69%
Drowsiness: 2 people, 7.69%
Discomfort: 2 people, 7.69%
Constipation: 2 people, 7.69%

What are the existing conditions these people have? *

Ill-Defined Disorder: 2 people, 7.69%
Stress And Anxiety: 1 person, 3.85%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Strattera and have Premature ejaculation?

- Check whether Premature ejaculation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Strattera:

Strattera (29,324 reports)

Browse all side effects of Strattera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Premature ejaculation:

Premature ejaculation (32 drugs)

Browse all the conditions that are associated with Premature ejaculation:

Premature ejaculation (173 conditions)

Related publications that referenced our studies

Salama N, Eid A, Swedan A, Hatem A, "Increased prevalence of premature ejaculation in men with metabolic syndrome", The Aging Male, 2017 Feb .
Salama N, Eid A, Swedan A, Hatem A, "Increased prevalence of premature ejaculation in men with metabolic syndrome", The Aging Male, 2017 Feb .

How the study uses the data?

The study uses data from the FDA. It is based on atomoxetine hydrochloride (the active ingredients of Strattera) and Strattera (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.